Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Organon and Co
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of asthma of at least 6 months duration
Current use of a medium or high daily dose of an inhaled corticosteroid (ICS) (alone or in combination with a long-acting beta agonist \[LABA\]) for at least 6 weeks prior to Screening AND must be on a stable asthma regimen (daily dose unchanged) for at least 2 weeks prior to Screening
Agrees to change asthma therapy (if changing asthma therapy poses no inherent risk)
If female of reproductive potential, agrees to remain abstinent or use 2 acceptable methods of birth control during study participation. Acceptable methods of birth control are: intrauterine device (IUD), diaphragm with spermicide, contraceptive sponge, condom, vasectomy, hormonal contraceptive
You may not be if
Treatment in the emergency room (for a severe asthma exacerbation), or admitted to the hospital for management of airway obstruction within previous 3 months
Any prior ventilator support for respiratory failure secondary to asthma,
Upper or lower respiratory tract infection (viral or bacterial) within previous 2 weeks
History of a medical condition that, in the investigator's opinion, may interfere with study participation,
History of smoking within previous year or a cumulative smoking history of more than 10 pack-years
Known allergy to or intolerance of ICSs, LABAs, or any of the ingredients included in the study medications
History of use of illicit drugs
Inability to correctly use an oral MDI
Pregnant, breastfeeding or plans to become pregnant during study
Clareo Health | Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)
